The role of first trimester fetal heart rate in the prediction of gestational diabetes: A multicenter study.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 21 05 2019
revised: 12 10 2019
accepted: 17 10 2019
pubmed: 11 11 2019
medline: 23 4 2020
entrez: 10 11 2019
Statut: ppublish

Résumé

Early pregnancy models for prediction of GDM have been proposed, mostly using anamnestic and biochemical parameters. The aim of our study was to evaluate the strength of association of first trimester fetal heart rate (FHR) in predicting the development of gestational diabetes (GDM). We considered in our analysis singleton non-diabetic pregnant women who underwent a first trimester screening at 11-14 weeks. Data on maternal age, BMI, cigarette smoking, NT, FHR, CRL, DV-PVI, β-hCG and PAPP-A were included in the analysis. Multivariate logistic regression analysis was used to estimate the association between maternal characteristics and first-trimester ultrasound measurements and GDM. We evaluated the efficacy of different models for the prediction of GDM. We considered 603 women, of whom 199 (33%) were subsequently diagnosed with GDM. ROC analysis showed that first trimester FHR was highly predictive of GDM (AUC 0.809, 95% CI 0.769-0.849, p < 0.001). At FPR of 20%, first trimester FHR had a detection rate of 65.2% for GDM (positive likelihood ratio: 3.26; negative likelihood ratio: 0.43), which increased to 89.5% at FPR of 40% (positive likelihood ratio: 2.24; negative likelihood ratio: 0.17). When considering as threshold 162 bpm, FHR showed detection rate of 76.9%, specificity of 67.1% and negative predictive value of 85.5% for GDM. This is the first study to highlight the potential role of first trimester FHR as early predictor of GDM. In our cohort, a threshold of 162 bpm has shown high detection rate and NPV for GDM.

Identifiants

pubmed: 31706055
pii: S0301-2115(19)30475-0
doi: 10.1016/j.ejogrb.2019.10.019
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

158-161

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Angelo Sirico (A)

Obstetrics and High-Risk Unit - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Neurosciences, Reproductive and Dentistry Sciences, University of Naples Federico II, Naples, Italy.

Antonio Lanzone (A)

Obstetrics and High-Risk Unit - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Ilenia Mappa (I)

Division of Maternal and Fetal Medicine, Ospedale Cristo Re - University of Rome Tor Vergata, Rome, Italy.

Laura Sarno (L)

Department of Neurosciences, Reproductive and Dentistry Sciences, University of Naples Federico II, Naples, Italy.

Maciej Słodki (M)

Division of Maternal and Fetal Medicine, Ospedale Cristo Re - University of Rome Tor Vergata, Rome, Italy; Department of Prenatal Cardiology in Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.

Dario Pitocco (D)

Diabetology Unit - Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Fulvio Zullo (F)

Department of Neurosciences, Reproductive and Dentistry Sciences, University of Naples Federico II, Naples, Italy.

Giuseppe Maria Maruotti (GM)

Department of Neurosciences, Reproductive and Dentistry Sciences, University of Naples Federico II, Naples, Italy.

Giuseppe Rizzo (G)

Division of Maternal and Fetal Medicine, Ospedale Cristo Re - University of Rome Tor Vergata, Rome, Italy; Department of Obstetrics and Gynecology, The First I.M. Sechenov Moscow State Medical University, Russia. Electronic address: giuseppe.rizzo@uniroma2.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH